000 04063nam a2200481 i 4500
999 _c382721
_d382721
001 382721
003 ES-MaUEC
005 20230102122008.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 220314s2022 sz | o |||| 0|eng d
020 _a9783030926168
024 7 _a10.1007/978-3-030-92616-8
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRL793
_b2022 EB
245 0 4 _aThe Immunogenetics of Dermatologic Diseases
_cedited by Nima Rezaei, Fateme Rajabi
250 _a1st edition 2022
264 1 _aCham
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XXI, 450 páginas)
_b64 ilustraciones, 62 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aAdvances in Experimental Medicine and Biology
_x2214-8019
_v1367
505 0 _aGenetics control of immune responses -- Non-melanoma skin cancer -- Melanoma -- Psoriasis -- Atopic dermatitis -- Contact dermatitis -- Lichen planus -- Pemphigus and pemphigoids -- Morphea and Lichen Sclerosus -- Granuloma annulare and Necrobiosis lipoidica -- Alopecia areata -- Vitiligo -- Acne Vulgaris and Rosacea -- Urticaria and Angioedema -- Cutaneous drug reaction -- Photodermatologic disorders -- Infantile Haemangioma and other vascular malformations.
520 _aThis book intends to investigate the broad spectrum of genetic changes in immunological processes involved in cutaneous diseases. One of the main goals of immunogenetic studies is finding susceptibility genes for complex diseases. This can provide an insight into the pathogenesis of the condition in a way that is not easily achievable through other kinds of studies. Thus they are a rational initial step for generating hypotheses about disease pathogenesis. This may especially benefit dermatology, a field notorious for having too many diseases with unknown etiologies. Immunogenetic investigations have made targeted treatment strategies possible for diseases such as psoriasis and pemphigus. Even though these strategies have revolutionized the management of chronic dermatological conditions such as psoriasis, still there are a lot of unanswered questions. For instance, psoriasis patients respond very differently to each of the commercially available biological agents. This diversity could be partially explained by the differences in the sets of genes responsible for disease induction in each individual. Thus whole genome sequencing strategies, if feasible at individual levels, might help in tailoring these targeted treatments based on specific genetic backgrounds. Our intention in preparing this book was to explore the broad spectrum of the genetic aspects of immunological processes involved in cutaneous diseases. We have tried to cover most areas of dermatology where enough studies were available to gather a chapter. Still, there is a substantial lack of knowledge on the immunogenetics of many dermatological conditions. We hope that this book would encourage the investigators to fill these gaps of knowledge.
988 _aSpringer_BiomedLife_2022
650 7 _2embne
_9168912
_aPiel
_xEnfermedades
_xAspectos inmunológicos
650 7 _2embne
_9138330
_aInmunología
700 _aRezaei, Nima
_eeditor literario
_988761
700 1 _aRajabi, Fateme.
_eeditor literario
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783030926151
776 0 8 _iPrinted edition:
_z9783030926175
776 0 8 _iPrinted edition:
_z9783030926182
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-92616-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b10/2022
_dz
_eb
_zSI